Skip to main content

Table 5 Multinomial regression of predictive factors associated with treatment success rate among patients treated for TB

From: Tuberculosis treatment outcome among patients treated in public primary healthcare facility, Addis Ababa, Ethiopia: a retrospective study

  COR (95% CI) AOR (95% CI)
Cured Vs unsuccessful treatment outcomeB(SE) B(SE) 
Age category, in years−0.02 (0.02)0.97 (0.94–0.0.99)*− 0.04 (0.05)0.91 (0.71–2.33)
HIV statusPositive 1.00 1.00
Negative2.2 (0.35)8.78 (4.41–17.51)**2.34 (1.8)6.1 (2.1–13.9)*
Unknown1.8 (1.1)6.00 (0.72–13.1)0.64 (1.68)1.9 (0.07–51.4)
Type of TBExtra PTB 1.00 1.00
Smear positive PTB2.8 (0.46)17.8 (7.2–43.8)**4.66 (1.2)10.5 (5.36–16.31)**
Smear negative PTB−1.4 (0.65)0.25 (0.071–0.89)*− 0.27 (1.1)0.77 (0.09–6.58)
TB treatment categoryNew 1.00 1.00
Retreatment−1.6 (0.27)0.52 (0.34–0.86)*− 1.1 (0.22)0.31 (0.05–0.59)
Transfer in0.85 (0.69)2.33 (0.60–9.02)0.54 (0.39)2.01 (0.87–3.65)
Treatment completed Vs unsuccessful treatment outcome
Age category in years−0.03 (0.02)0.97 (0.93–0.95)*− 0.016 (0.81)0.99 (0.81–2.99)
HIV statusPositive 1.00 1.00
Negative3.1 (0.34)21.4 (10.9–39.8)**2.07 (1.13)4.4 (1.26–15.58)*
Unknown0.65 (0.0.37)1.9 (0.92–3.91)0.18 (1.1)2.84 (0.096–7.3)
Type of TBExtra PTB 1.00 1.00
Smear positive PTB2.2 (0.31)9.1 (5.00–16.5)**4.26 (1.28)3.8 (1.25–7.4)**
Smear negative PTB3.46 (0.51)2.88 (1.17–7.39)**0.91 (0.62)1.73 (0.12–4.34)
TB treatment categoryNew 1.00 1.00
Re-treatment−1.3 (0.67)0.273 (0.024–0.81)*− 1.9 (0.86)0.15 (0.03–0.99)
Transfer in0.11 (1.04)1.42 (0.62–7.2)3.2 (1.65)2.11 (0.65–3.88)
  1. Note: R2 = 0.645 (Cox & Snell), 0.813 (Nagelkerke); Model χ2 = 364.7, Pearson (p = 0.73) and deviance(p = 0.894); * p < .05, ** p < .001